BPC-157

most data

Also seen as: Body Protection Compound 157, BPC, pentadecapeptide, Body Protection Compound-157

The Dose Guy’s verdict

Sep 1, 2026
4 sources

The most-run healing peptide for a reason. BPC-157 has the broadest animal evidence base in this column and the deepest community track record for soft-tissue and gut repair, and it is cheap and well tolerated. The honest catch: the human data has not caught up to the reputation. Three tiny uncontrolled pilots, no proper trial. For most people asking what to try first for a nagging injury or a beat-up gut, this is still the answer.

Would I take it?Yes, start here.

What it is

A fifteen-amino-acid fragment of a protein in human gastric juice, synthesized and studied since the 1990s for tissue repair. The mechanism story in the animal work is unusually broad: BPC-157 promotes blood vessel growth, upregulates growth factors, and works through the nitric oxide system to protect and rebuild damaged tissue. That breadth is why it shows up for everything from tendons and ligaments to gut lining to post-surgical recovery.

In the healing column it sits at the top because nothing else combines this much preclinical evidence with this many people actually running it. TB-500 is the usual partner, the other half of the standard healing stack: BPC-157 works more locally at the injury site, TB-500 acts more systemically. Pentadeca arginate is marketed as a more stable successor, but it has no independent data behind it yet.

What the research shows

A deep animal base, a nearly empty human one. That gap is the whole story:

A systematic review screened 544 records and included 36 studies. Thirty-five were preclinical. One was clinical.HSS J 2025 · systematic review · 36 studies

A scoping review found only three human pilot studies: intra-articular knee pain, interstitial cystitis, and intravenous safety.Curr Rev 2025 · scoping review

In twelve women with interstitial cystitis given injections totaling 10 mg during one procedure, ten reported complete symptom resolution and two rated improvement at 80%. No adverse events.ATHM 2024 · uncontrolled pilot · n=12

In rats after Achilles tendon transection, BPC-157 produced numerically better histology and load-to-failure scores without reaching statistical significance. TB-500, not BPC-157, was the one that hit significance on mechanical strength. The combination of BPC-157 and TB-500 produced no additional benefit over either agent alone.Jt Dis Relat Surg 2026 · rat RCT · n=32

Realistic protocols

Most people inject BPC-157 subcutaneously, as close to the injury as they can reach. Local injection is the community standard, the logic being you want the peptide where the damage is. For gut issues, oral dosing is the other route, taken on an empty stomach.

Start at the low end of 250 mcg once a day. If you feel improvement in the first couple of weeks, hold there: this is not a dose-escalation game, and the people who report the best outcomes tend to run moderate doses consistently rather than pushing high. A cycle runs four to eight weeks for most injuries. You can run it alongside TB-500 from day one, the standard healing stack, and most people do for anything structural, though the one rat study that tested the combination found no additional benefit over either peptide alone. Reconstitute with bacteriostatic water and keep it refrigerated.

Two daily-life notes. First, drop the NSAIDs while you run it: you are trying to rebuild tissue, and anti-inflammatories work against the repair process BPC-157 is meant to support. Second, keep training the area if you can, but keep it light and progressive. The community consensus is that BPC-157 works better alongside controlled loading than total rest.

BPC-157 is on WADA’s prohibited list and can be detected in urine. If you compete in tested sports, know that before you start.

Standard250–500 mcg/daySub-q near the injury, or split AM/PM. Start low and hold if it's working.

Gut protocol250–500 mcg/dayOral on an empty stomach for gut and inflammatory issues.

The stack+ TB-500BPC-157 local, TB-500 systemic. The default healing pairing.

Duration4–8 weeksReassess at four weeks. Extend if healing is still moving.

Side effects

One of the cleanest side profiles in the peptide world, which is part of why it is the default starter:

anecdotalMild injection-site redness or a light head-rush right after pinning. Usually gone in minutes.

anecdotalTemporary digestive discomfort on oral dosing, mostly in the first few days.

unknownNo long-term human safety data exists. Thirty-five of thirty-six included studies were preclinical, and three tiny uncontrolled pilots is not the same as studied for years in people. A peptide that promotes blood vessel growth and upregulates growth factors deserves the same caution as any growth signal without a human safety record.